Teleflex (NYSE:TFX) Reaches New 52-Week Low – Should You Sell?

Teleflex Incorporated (NYSE:TFX) shares reached a new 52-week low on Friday . The stock traded as low as $171.63 and last traded at $173.45, with a volume of 57596 shares changing hands. The stock had previously closed at $173.62.

Wall Street Analyst Weigh In

TFX has been the topic of a number of recent analyst reports. Royal Bank of Canada dropped their price target on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st. Mizuho reduced their price objective on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, November 1st. Truist Financial cut their price target on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Finally, StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $252.50.

Teleflex Stock Performance

The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The stock has a 50 day simple moving average of $180.48 and a two-hundred day simple moving average of $211.61. The company has a market capitalization of $8.03 billion, a price-to-earnings ratio of 34.37, a PEG ratio of 1.78 and a beta of 1.16.

Hedge Funds Weigh In On Teleflex

Institutional investors and hedge funds have recently modified their holdings of the company. Janus Henderson Group PLC boosted its stake in Teleflex by 2.8% during the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock valued at $1,329,704,000 after purchasing an additional 147,147 shares during the period. FMR LLC increased its position in Teleflex by 70.1% in the 3rd quarter. FMR LLC now owns 269,490 shares of the medical technology company’s stock worth $66,650,000 after purchasing an additional 111,086 shares during the last quarter. Assenagon Asset Management S.A. lifted its stake in shares of Teleflex by 457.6% in the 3rd quarter. Assenagon Asset Management S.A. now owns 120,311 shares of the medical technology company’s stock valued at $29,755,000 after purchasing an additional 98,735 shares during the last quarter. Point72 Asset Management L.P. raised its holdings in Teleflex by 31.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock worth $100,768,000 after acquiring an additional 96,958 shares during the period. Finally, Parkman Healthcare Partners LLC acquired a new position in shares of Teleflex during the third quarter valued at about $23,778,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.